Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations
出版年份 2016 全文链接
标题
Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations
作者
关键词
Biomarker, Immunotherapy, Cancer, Assay, Validation, Regulatory
出版物
Journal for ImmunoTherapy of Cancer
Volume 4, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-11-09
DOI
10.1186/s40425-016-0179-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology
- (2017) Phillip G. Febbo et al. Journal of the National Comprehensive Cancer Network
- Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial
- (2015) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regularization Paths for Generalized Linear Models via Coordinate Descent
- (2015) Jerome Friedman et al. Journal of Statistical Software
- FDA Perspective on Companion Diagnostics: An Evolving Paradigm
- (2014) E. A. Mansfield CLINICAL CANCER RESEARCH
- Cancer Drug Development and the Evolving Regulatory Framework for Companion Diagnostics in the European Union
- (2014) F. Pignatti et al. CLINICAL CANCER RESEARCH
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- Companion Diagnostics for Targeted Cancer Drugs – Clinical and Regulatory Aspects
- (2014) Dana Olsen et al. Frontiers in Oncology
- Measuring the Performance of Markers for Guiding Treatment Decisions
- (2013) Holly Janes et al. ANNALS OF INTERNAL MEDICINE
- ReCount: A multi-experiment resource of analysis-ready RNA-seq gene count datasets
- (2011) Alyssa C Frazee et al. BMC BIOINFORMATICS
- Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20
- (2011) Gong Tang et al. BREAST CANCER RESEARCH AND TREATMENT
- Assessing the Clinical Utility of Diagnostics Used in Drug Therapy
- (2010) J Woodcock CLINICAL PHARMACOLOGY & THERAPEUTICS
- Improved Endpoints for Cancer Immunotherapy Trials
- (2010) A. Hoos et al. JNCI-Journal of the National Cancer Institute
- Randomized Clinical Trials With Biomarkers: Design Issues
- (2010) B. Freidlin et al. JNCI-Journal of the National Cancer Institute
- Transcriptome genetics using second generation sequencing in a Caucasian population
- (2010) Stephen B. Montgomery et al. NATURE
- Understanding mechanisms underlying human gene expression variation with RNA sequencing
- (2010) Joseph K. Pickrell et al. NATURE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical Challenges
- (2009) Sumithra J. Mandrekar et al. JOURNAL OF CLINICAL ONCOLOGY
- Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
- (2008) Rafael G. Amado et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More